BIOALPHA Holdings Bhd’s big move into the China market amidst the ongoing Covid-19 pandemic is noteworthy.
Despite the worldwide lockdown restrictions led by the pandemic, the integrated health supplement company took bold steps in expanding its footprint in China’s health supplements market.
In its latest joint venture with Suzhou Medicalsystem Technology Co Ltd (MEDIC) for the commercialisation of Biolapha’s proprietary herbal formulations and products in China, the company will roll out five products in the country by mid-2022, says William Hon, the managing director of Bioalpha Holdings Bhd.
...